Sort
82,697 grants matching “vaccine development”
Novel mechanisms regulating immunity to respiratory virus infection
$913,500Silke Paust · Jackson Laboratory · R01 · FY2023 · AI
Administrative Core
$913,406Kevin Sean Kimbro · Morehouse School Of Medicine · U54 · FY2025 · MD
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
$913,378Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2022 · AI
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$913,220Richard K. Plemper · Georgia State University · R01 · FY2023 · AI
Clinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$913,169Raphael Dolin · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI
Rational Design of Immunogens Targeting HIV-1 Quaternary Neutrlizing Epitopes
$913,133Xiangpeng Kong · New York University School Of Medicine · P01 · FY2017 · AI
Assessing the mechanisms underlying female sex-predominance in Long COVID
$913,012Michael Joseph Peluso · University Of California, San Francisco · R01 · FY2025 · AI
Structure-Based Design of Drugs and Vaccines for Target*
$912,946Rutgers The St Univ Of Nj New Brunswick · P01 · FY2004 · GM
Entry and replication of positive-sense, RNA viruses
$912,922Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies
$912,815Laurent Karl Verkoczy · San Diego Biomedical Research Institute · R01 · FY2020 · AI
Combining membrane Env vaccine regimens to elicit multiple bnAb lineages and consistent cross-neutralization of HIV
$912,596Michael B Zwick · Scripps Research Institute, The · R01 · FY2025 · AI
HIV-Receptor Interactions and Related Anti-HIV Strategies
$912,524Edward Berger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
CANDIDA ADHERENCE MYCOLOGY RESEARCH UNIT
$912,518La Biomed Res Inst/ Harbor Ucla Med Ctr · P01 · FY2002 · AI
Kinetics, evolution, and effector function of Fc repertoires during vaccination with native-like Env trimers
$912,255D. Noah Sather · Seattle Children'S Hospital · R01 · FY2019 · AI
Pre-clinical Vaccine Development for Respiratory Viruses
$912,113Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases
$912,113Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Malaria Vaccine Trials in Mali
$912,060Christopher V. Plowe · University Of Maryland Baltimore · U19 · FY2009 · AI
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2021 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2016 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2017 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2020 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2015 · CA
Fusion peptide directed immunogens that elicit neutralizing and protective antibodies in non-human primates
$911,877Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2020 · AI
An Orally Delivered Booster Vaccine Candidate for Hepatitis B
$911,830John A. Howard · Applied Biotechnology Institute · R44 · FY2013 · AI
Vector Biological Studies in Leishmaniasis
$911,807David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI